Qmed Asia aims to solve the healthcare needs of Asia by implementing digital health solutions throughout the region. If you had your Covid-19 vaccine or booster shots from Mega PPVs such as PWTC, KLCC, and IDCC, chances are that the entire operations of these centres were efficiently carried out by Qmed Asia, whom were the official partner for operating 42 such COVID-19 vaccination centres during the pandemic.
But who are the people behind Qmed Asia, and why are we sharing their story?
Qmed Asia was founded by a group of passionate doctors who collectively had one idea — to provide quality medical services across Asia via advanced technology. Formerly known as QueueMed, their journey began as an appointment booking and mobile live queue system provider for the healthcare industry, as mentioned with the Covid-19 PPV centres.
To date, they have onboarded over 4,000 healthcare providers from the private and public sectors and served more than 2 million patients nationwide. Having managed more than 11 million bookings, they have effectively reduced the average patient wait time from 2.5 hours to just 30 minutes!
Today however, Qmed Asia serves as an all-in-one healthcare companion for healthcare providers and patients. Patients can enjoy a comprehensive range of online healthcare services, from online bookings and online queueing to tele-consultations with smart IoT monitoring to getting medical care at home. Qmed Asia is also financially strong with revenues that have grown to RM12 million whilst also being profitable within just 3 years of being incorporated, a big feat for a startup in the healthcare space.
Having been the recipient of multiple awards as recognition for their innovation capabilities by both local and international organisations, Qmed Asia has gone on to win the trust of prominent clients and signed partnerships with Nestlé Malaysia, SP Setia Group, Qualitas Medical Group and Lippo Life Indonesia.
Dr. Kev Lim, CEO & Founder of Qmed Asia recently shared his thoughts on BFM 89.9 Station, “We’re here to make an impact first for healthcare! I’ve been running this healthcare technology company for the past four years, and I’ve been fortunate to have a wonderful team of top talents working together to impact the healthcare industry through cutting-edge technologies. We are now looking forward to welcoming and inviting more like-minded healthcare professionals and investors to join us in our next growth phase toward making healthcare better and more accessible to all through equity crowdfunding.”
To facilitate this, Qmed Asia is currently raising RM6 million via equity crowdfunding (ECF) on Leet Capital, with more than RM1 million raised so far.
“The funds raised will be used for our regional market expansion by implementing our digital health solutions into the Indonesian market next, alongside ongoing discussions with other regional market stakeholders in the Philippines and Vietnam. We will also be strengthening our technological innovation with more deep tech development and will be preparing to roll-out more value-based digital health solutions for healthcare providers.”
Qmed Asia will be offering limited time incentives worth up to RM8,000, together with bonus shares up to 15% for early bird investments. To learn more about their ECF deal, head over to https://leet.capital/company/Qmed-Asia.